home / stock / san / san news


SAN News and Press, Banco Santander S.A. Sponsored ADR From 02/04/26

Stock Information

Company Name: Banco Santander S.A. Sponsored ADR
Stock Symbol: SAN
Market: NYSE
Website: santander.com

Menu

SAN SAN Quote SAN Short SAN News SAN Articles SAN Message Board
Get SAN Alerts

News, Short Squeeze, Breakout and More Instantly...

SAN - Banco Santander GAAP EPS of Euro0.24, total income of Euro15.16B

2026-02-04 00:17:30 ET More on Banco Santander Banco Santander: I Am Cautious As The Long-Term Risk-Reward Proposition Is Not Great Banco Santander: Major Re-Rating Diminishes The Value Case (Downgrade) Banco Santander, S.A. 2025 Q3 - Results - Earnings Call Presenta...

SAN - Banco Santander to acquire Webster Financial in ~$12.3B cash-and-stock deal

2026-02-03 14:40:05 ET More on Webster Financial, Banco Santander Banco Santander: I Am Cautious As The Long-Term Risk-Reward Proposition Is Not Great Webster Financial Corporation 2025 Q4 - Results - Earnings Call Presentation Webster Financial: Low-Cost Deposit Gro...

SAN - Webster Financial Corporation Enters Into Merger Agreement With Banco Santander, S.A. for $12.3 Billion

Creates Top Ten Retail and Commercial Bank by Assets Nationwide Establishes Top Five Bank by Deposits in the Northeast Transaction Provides Compelling Value for Webster Stockholders Webster Financial Corporation (NYSE: WBS), the holding company for Webster Bank, N.A., ...

SAN - Sanofi's venglustat demonstrates mixed results in late-stage rare disease trials

2026-02-02 14:46:15 ET More on Sanofi Sanofi (SAN:CA) Q4 2025 Earnings Call Transcript Sanofi 2025 Q4 - Results - Earnings Call Presentation Sanofi (SAN:CA) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript Sanofi anticipates profitable gro...

SAN - Perspective Therapeutics: VMT-A-NET Presses On In SSTR2-Solid Tumor Targeting Space

2026-01-30 15:37:07 ET The last time I spoke about Perspective Therapeutics, Inc. ( CATX ), it was in a Seeking Alpha article entitled " Perspective: VMT01/02 Melanoma Data Coming For Radiotherapeutic Proof-Of-Concept ." With respect to this article, I talked about its radio...

SAN - Sanofi graft-versus-host disease asset Rezurock gains EU approval recommendation

2026-01-30 08:51:51 ET More on Sanofi Sanofi (SAN:CA) Q4 2025 Earnings Call Transcript Sanofi 2025 Q4 - Results - Earnings Call Presentation Sanofi (SAN:CA) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript Sanofi anticipates profitable gro...

SAN - Regeneron posts Q4 beat as Sanofi collaboration offsets Eylea headwinds

2026-01-30 07:07:49 ET More on Regeneron Pharmaceuticals, Sanofi, etc. Sanofi (SAN:CA) Q4 2025 Earnings Call Transcript Sanofi 2025 Q4 - Results - Earnings Call Presentation Regeneron: Q4 Earnings Preview - Why I'm Expecting A Beat And Strong 2026 Regeneron P...

SAN - Sanofi (SAN:CA) Q4 2025 Earnings Call Transcript

2026-01-29 15:22:27 ET Sanofi (SAN:CA) Q4 2025 Earnings Call January 29, 2026 8:30 AM EST Company Participants Thomas Larsen - Head of Investor Relations & General Medicines Paul Hudson - CEO & Director François-Xavier Roger - Executive VP & CFO ...

SAN - Santander US Finds Middle-Income Americans Optimistic about Finances, See Benefits of AI for Car Buying and Managing Finances

Middle-income households continue to display resiliency, as confidence remains at a three-year high despite ongoing price pressures. AI is seen as supporting middle-income Americans’ pursuit of financial prosperity. Auto demand remains elevated, as consumers prioritize vehicle acce...

SAN - Sanofi anticipates profitable growth to continue over at least five years

2026-01-29 04:09:34 ET More on Sanofi Sanofi (SAN:CA) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript Sanofi (SAN:CA) Discusses Year-End Late-Stage Pipeline Review With Focus on Clinical and Regulatory Developments Transcript Sanofi (SAN:CA) Disc...

Previous 10 Next 10